6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil has been researched along with HIV Coinfection in 1 studies
6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil: an anti-HIV agent; structure in first source
6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil : A pyrimidone that is uracil which is substituted at positions 1, 5, and 6 by ethoxymethyl, isopropyl, and 3,5-dimethylbenzyl groups, respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tanaka, H | 1 |
Takashima, H | 1 |
Ubasawa, M | 1 |
Sekiya, K | 1 |
Inouye, N | 1 |
Baba, M | 1 |
Shigeta, S | 1 |
Walker, RT | 1 |
De Clercq, E | 1 |
Miyasaka, T | 1 |
1 other study available for 6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil and HIV Coinfection
Article | Year |
---|---|
Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.
Topics: Animals; Antiviral Agents; Benzyl Compounds; HIV Infections; HIV-1; Humans; Lymphocytes; Mice; Micro | 1995 |